| 0 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
1 |
0.0008 |
| 1 |
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] |
1 |
0.0004 |
| 2 |
Complement Inhibitor [EPC] |
15 |
0.0003 |
| 3 |
Histone Deacetylase Inhibitor [EPC] |
1 |
0.0003 |
| 4 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
1 |
0.0001 |
| 5 |
Orexin Receptor Antagonist [EPC] |
1 |
0.0001 |
| 6 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 7 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
1 |
0.0000 |
| 8 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 9 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 10 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Vitamin D [EPC] |
3 |
0.0000 |
| 12 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 13 |
Parathyroid Hormone Analog [EPC] |
1 |
0.0000 |
| 14 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 16 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 17 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 18 |
Prostacycline Vasodilator [EPC] |
1 |
0.0000 |
| 19 |
Vitamin C [EPC] |
3 |
0.0000 |
| 20 |
Leukocyte Growth Factor [EPC] |
1 |
0.0000 |
| 21 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 22 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 24 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 25 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 26 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 27 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 28 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 29 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 30 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Corticosteroid [EPC] |
2 |
0.0000 |
| 32 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 33 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |